Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
ETFs
Etats-Unis
AMEX
WisdomTree Bitcoin Fund (BTCW)
WisdomTree Bitcoin Fund (BTCW) Options

WisdomTree Bitcoin Fund (BTCW)

63,6911

-3,52

(-5,24%)

Fermé 06 Juin 10:00PM

65,08

1,39

(2,18%)

Après les heures de négociation: 1:59AM

WisdomTree Bitcoin Fund ([symbol]) Options

BTCW Flux des options

Achats

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
45,00	18,20	19,70	0,00	18,95	0,00	0,00 %	0	0	-
50,00	13,30	14,90	21,17	14,10	0,00	0,00 %	0	11	-
55,00	8,70	10,20	16,24	9,45	-0,00	0,00 %	0	11	-
60,00	4,40	5,90	11,42	5,15	0,00	0,00 %	0	52	-
65,00	1,45	2,80	0,00	2,125	0,00	0,00 %	0	0	-
70,00	0,20	1,30	0,00	0,75	0,00	0,00 %	0	0	-
75,00	0,00	0,90	4,50	4,50	0,00	0,00 %	0	2	-
76,00	0,00	0,85	0,00	0,00	0,00	0,00 %	0	0	-
77,00	0,00	0,85	0,00	0,00	0,00	0,00 %	0	0	-
78,00	0,00	0,80	0,00	0,00	0,00	0,00 %	0	0	-
79,00	0,00	0,80	0,00	0,00	0,00	0,00 %	0	0	-
80,00	0,00	0,85	0,00	0,00	0,00	0,00 %	0	0	-
81,00	0,00	0,85	0,00	0,00	0,00	0,00 %	0	0	-
82,00	0,00	0,75	0,00	0,00	0,00	0,00 %	0	0	-

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Ventes

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
45,00	0,00	0,85	0,00	0,00	0,00	0,00 %	0	0	-
50,00	0,00	1,05	0,00	0,00	0,00	0,00 %	0	0	-
55,00	0,10	1,40	0,00	0,75	0,00	0,00 %	0	0	-
60,00	0,80	2,20	0,00	1,50	0,00	0,00 %	0	0	-
65,00	2,70	4,00	3,70	3,35	2,24	153,42 %	1	10	05/6/2026
70,00	6,20	7,70	0,00	6,95	0,00	0,00 %	0	0	-
75,00	10,70	12,10	9,14	11,40	0,00	0,00 %	0	2	-
76,00	11,60	13,10	0,00	12,35	0,00	0,00 %	0	0	-
77,00	12,60	14,10	0,00	13,35	0,00	0,00 %	0	0	-
78,00	13,60	15,10	0,00	14,35	0,00	0,00 %	0	0	-
79,00	14,60	16,10	2,62	15,35	0,00	0,00 %	0	13	-
80,00	15,60	17,00	2,30	16,30	0,00	0,00 %	0	1	-
81,00	16,60	18,00	0,00	17,30	0,00	0,00 %	0	0	-
82,00	17,60	19,00	0,00	18,30	0,00	0,00 %	0	0	-

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SCAGScage Future	US$ 0,8489 (196,61%)	92,75M
SPHLSpringview Holdings Ltd	US$ 5,38 (125,20%)	40,61M
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M
STISolidion Technology Inc	US$ 35,50 (56,32%)	38,55M
NUWENewellis Inc	US$ 0,1625 (-62,30%)	50M
NYXHNyxoah SA	US$ 1,41 (-51,04%)	2,47M
CYPHCypherpunk Technologies Inc	US$ 0,5176 (-47,26%)	30,53M
TDICDreamland Ltd	US$ 0,2277 (-37,68%)	12,09M
FOFOHang Feng Technology Innovation Co Ltd	US$ 3,91 (-36,73%)	381,9k
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
SNBRSleep Number Corporation	US$ 0,477 (36,25%)	305,13M
SMTKSmartKem Inc	US$ 0,419101 (30,97%)	232,19M
NVDANVIDIA Corporation	US$ 205,10 (-6,20%)	220,65M
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M

DTGoody

DTGoody il y a 4 minutes

Yes, I was playing that Damn VMH* which appears I jinxed as usual! That's another one pissing me off! LOL I could have bought a ton more shares here if I reacted better to the news and switched things around if you know what I mean. Instead, I had my thumb up my Rear while this Gem keeps running! LO

Myth

Myth il y a 4 minutes

Hand Of Fate · The Rolling Stones

https://www.youtube.com/watch?v=3RGhtDjup38

badshah

badshah il y a 5 minutes

School teacher...but you have no shares...so why the interest????

dewophile

dewophile il y a 6 minutes

I’ll check it out thanks. A key point is that ketones can rise even when glucose levels are within range. I’m not sure the commercial opportunity but it sounds not only limited to type 1 diabetics. It also seems like dexcom has greater market share in intensive insulin users and this is the populati

Myth

Myth il y a 6 minutes

The Rolling Stones - One Hit (To The Body)

https://www.youtube.com/watch?v=dx2WRQLSIew

1plus1

1plus1 il y a 6 minutes

A Once in a lifetime opportunity, BIEI will make history next week in Mexico, World Cup and we sponsor the product … possible dream come true

jerkviewer

jerkviewer il y a 6 minutes

i would love to know what he thinks our chances are

jerkviewer

jerkviewer il y a 7 minutes

it might not be such a longshot....it definitely would change the valuation....nas will hopefully expand on that topic on the cc

eur06

eur06 il y a 8 minutes

ok it’ll be fine to wait, no rush from me.
GLND

1plus1

1plus1 il y a 11 minutes

LET'S HOPE THEY WILL USE THE PRODUCTS IN FIFFA CUP NEXT WEEK >> THIS WILL BE SWEEEEEEEEEEET AND OVER .10+ CENTS

FOFreddie

FOFreddie il y a 12 minutes

Ackman is a billionaire friend who would probably this resolved ASAP. John Paulson is a billionaire friend who also probably wants this resolved ASAP. They really need to come out with a Housing Plan ASAP as you mentioned. Also - why would Trump want to leave any money on the table for the nex

DTGoody

DTGoody il y a 12 minutes

Why would Cohen be involved with ENCC??? I'm sorry, but I don't see the connection between him and ENCC.

DTGoody

DTGoody il y a 14 minutes

We will be on entirely differently exchange then!

flipper44

flipper44 il y a 14 minutes

NWBO was entrusted with this technology well over decades ago. Their perseverance is commendable, but their execution, communication, morphing plans, spending, and red zone efficiency, and that of MHRA, are reasonably subject to scrutiny.

GR8 Dad

GR8 Dad il y a 14 minutes

If you ride the o t c you're gonna lose some money, even a child knows that.

Make sure your winners are bigger than your losers.That's the only way to play it.

The o t c is the world's largest casino, where the only game is liars poker.

Riding many, many,

Myth

Myth il y a 15 minutes

Blow Wind Blow · Eric Clapton

https://www.youtube.com/watch?v=aE-QoPDxijc

DewDiligence

DewDiligence il y a 15 minutes

Berobenatide—dosed monthly—appears_competitive_with_weekly Zepbound/Wegovy in efficacy/tolerability—see slide 7 at the link in #msg-177679183.

Berobenatide (f/k/a ‘3944) is the lead compound from PFE’s weight-loss pipeline acquired in the Metsera buyout (#msg-176942527).

joe botts

joe botts il y a 16 minutes

tisdal

tisdal il y a 17 minutes

Nice Job on the Research CW. That opened my eyes to truly understand what the GARB Report's purpose was. That GARB Report was a preliminary document to establish hydrocarbon potential justifying the 3D Seismic, and after analyzing that data, if drilling would be justifiable.

The sta

FOFreddie

FOFreddie il y a 18 minutes

The Brydon Fisher lawsuit was a Derivative lawsuit which would have returned the damages back to Fannie and Freddie for the benefit of shareholders. The Lamberth/Berkeley lawsuit is a Class Action but the issue so far is that damages were severely limited. We wait for the Decision on Restitution

DewDiligence

DewDiligence il y a 21 minutes

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

jour_trader

jour_trader il y a 21 minutes

Would certainly be astronomical, just don’t think the odds are in our favor. We’ll know soon enough via lawsuit or cc if paragraph IV was pursued.

DewDiligence

DewDiligence il y a 22 minutes

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

JamesF1

JamesF1 il y a 22 minutes

I look at the possibility of Elite successfully getting a paragraph 4 approval for Eliquis as a long shot. Long shots occasionally come in.

WisdomTree Bitcoin

Plandai Biotechnology (ID)

Host Hotels and Resorts

Tasman Resources

Abrdn Asia Pacific Incom...

Atea Pharmaceuticals

Almonty Industries

OrthoPediatrics

TriplePoint Venture Grow...

Brenmiller Energy

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.